Related Experiment Video
Updated: Jun 6, 2026

05:45
Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
Published on: July 31, 2017
Chromogranin A and the tumor microenvironment.
1Division of Molecular Oncology and IIT Network Research Unit of Molecular Neuroscience, San Raffaele Scientific Institute, via Olgettina 58, 20132 Milan, Italy. corti.angelo@hsr.it
Cellular and Molecular Neurobiology
|November 17, 2010
Summary
Chromogranin A (CgA) is a protein marker used for neuroendocrine tumors. Emerging research shows CgA also influences the tumor microenvironment, potentially impacting cancer progression and treatment response.
Area of Science:
- Biochemistry
- Oncology
- Cell Biology
Background:
- Chromogranin A (CgA) is a regulated secretory protein found in neuroendocrine cells.
- CgA serves as a diagnostic and prognostic serum marker for neuroendocrine tumors.
- Elevated CgA levels are also observed in non-neuroendocrine tumors, indicating broader prognostic relevance.
Purpose of the Study:
- To review recent findings on Chromogranin A's role beyond a diagnostic marker.
- To discuss CgA's influence on the tumor microenvironment.
- To explore CgA's potential impact on tumor progression and therapy response.
Main Methods:
- Review of in vitro experimental results.
- Analysis of in vivo studies in animal models.
- Synthesis of recent scientific literature.
Main Results:
- Evidence suggests CgA and its fragments modulate the tumor microenvironment.
- CgA affects key components like fibroblasts and endothelial cells.
- Abnormal CgA secretion may play a role in tumor progression.
Conclusions:
- Chromogranin A is implicated as a modulator of the tumor microenvironment.
- Altered CgA secretion could significantly influence cancer progression and therapeutic outcomes.
- CgA represents a potential therapeutic target and prognostic indicator in broader cancer contexts.
Related Concept Videos
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
